Literature DB >> 26592823

MiR-16 regulates cell death in Alzheimer's disease by targeting amyloid precursor protein.

B Zhang1, C-F Chen, A-H Wang, Q-F Lin.   

Abstract

OBJECTIVE: The aim of this study was to investigate the role of miR-16 in Alzheimer's disease (AD) and to explore its mechanism of action.
MATERIALS AND METHODS: A cellular AD model using PC12 cells and primary hippocampal neurons was established to evaluate the expression level of miR-16. Transfection of a miR-16 mimic and a miR-16 inhibitor were performed to explore its effect on cell apoptosis and cell viability. In addition, we carried out bioinformatics analysis, luciferase reporting gene assay, and gene expression analyses to identify the potential target of miR-16 and to verify the effect of the target gene on the cellular AD model.
RESULTS: Downregulation of miR-16 was confirmed in the cellular AD model with both PC12 cells (p < 0.05) and primary hippocampal neurons (p < 0.05). Overexpression and inhibition of miR-16 in the cellular AD model with primary hippocampal neurons decreased and increased apoptosis, respectively. The gene encoding amyloid precursor protein (APP) was identified as the target gene of miR-16. Knockdown of APP in primary hippocampal neurons decreased cell apoptosis and increased cell viability in the cellular AD model.
CONCLUSIONS: Our results demonstrate that downregulation of miR-16 in primary hippocampal neurons play an important role in the paracrine effect and might be involved in the development of AD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26592823

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  16 in total

Review 1.  Noncoding RNAs in Alzheimer's disease.

Authors:  M Laura Idda; Rachel Munk; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-01-12       Impact factor: 9.957

Review 2.  Cerebral Amyloid Angiopathy, Alzheimer's Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets.

Authors:  J Weldon Furr; Diego Morales-Scheihing; Bharti Manwani; Juneyoung Lee; Louise D McCullough
Journal:  Neuromolecular Med       Date:  2019-10-04       Impact factor: 3.843

Review 3.  Epigenetic mechanisms of neurodegenerative diseases and acute brain injury.

Authors:  Mario J Bertogliat; Kahlilia C Morris-Blanco; Raghu Vemuganti
Journal:  Neurochem Int       Date:  2019-12-12       Impact factor: 3.921

Review 4.  Transcriptional and Post-Transcriptional Regulations of Amyloid-β Precursor Protein (APP) mRNA.

Authors:  Kaoru Sato; Ken-Ichi Takayama; Makoto Hashimoto; Satoshi Inoue
Journal:  Front Aging       Date:  2021-08-11

Review 5.  A critical evaluation of neuroprotective and neurodegenerative MicroRNAs in Alzheimer's disease.

Authors:  P Hemachandra Reddy; Sahil Tonk; Subodh Kumar; Murali Vijayan; Ramesh Kandimalla; Chandra Sekhar Kuruva; Arubala P Reddy
Journal:  Biochem Biophys Res Commun       Date:  2016-08-12       Impact factor: 3.575

6.  miR-98-5p Acts as a Target for Alzheimer's Disease by Regulating Aβ Production Through Modulating SNX6 Expression.

Authors:  Qiushi Li; Xidong Li; Li Wang; Yanhui Zhang; Long Chen
Journal:  J Mol Neurosci       Date:  2016-08-19       Impact factor: 3.444

7.  Knockdown of long non-coding RNA TUG1 depresses apoptosis of hippocampal neurons in Alzheimer's disease by elevating microRNA-15a and repressing ROCK1 expression.

Authors:  Xia Li; Sheng-Wu Wang; Xi-Ling Li; Feng-Yuan Yu; Hai-Ming Cong
Journal:  Inflamm Res       Date:  2020-06-23       Impact factor: 6.986

8.  Hippocampal MicroRNAs Respond to Administration of Antidepressant Fluoxetine in Adult Mice.

Authors:  Nan Miao; Junghee Jin; Seung-Nam Kim; Tao Sun
Journal:  Int J Mol Sci       Date:  2018-02-27       Impact factor: 5.923

Review 9.  Effect of Regulatory Network of Exosomes and microRNAs on Neurodegenerative Diseases.

Authors:  Dong Li; You-Ping Li; Yun-Xiang Li; Xiao-Hua Zhu; Xiao-Gang Du; Min Zhou; Wen-Bin Li; Hong-Yan Deng
Journal:  Chin Med J (Engl)       Date:  2018-09-20       Impact factor: 2.628

10.  MicroRNA Expression Levels Are Altered in the Cerebrospinal Fluid of Patients with Young-Onset Alzheimer's Disease.

Authors:  Paul M McKeever; Raphael Schneider; Foad Taghdiri; Anna Weichert; Namita Multani; Robert A Brown; Adam L Boxer; Anna Karydas; Bruce Miller; Janice Robertson; Maria Carmela Tartaglia
Journal:  Mol Neurobiol       Date:  2018-03-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.